Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Minority Interest (2020 - 2022)

Purple Biotech has reported Minority Interest over the past 3 years, most recently at $187000.0 for Q4 2022.

  • Quarterly Minority Interest fell 32.97% to $187000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $187000.0 through Dec 2022, down 32.97% year-over-year, with the annual reading at $187000.0 for FY2022, 32.97% down from the prior year.
  • Minority Interest was $187000.0 for Q4 2022 at Purple Biotech, down from $279000.0 in the prior quarter.
  • Over five years, Minority Interest peaked at $363000.0 in Q4 2020 and troughed at $187000.0 in Q4 2022.
  • The 3-year median for Minority Interest is $279000.0 (2021), against an average of $276333.3.
  • Year-over-year, Minority Interest decreased 23.14% in 2021 and then tumbled 32.97% in 2022.
  • A 3-year view of Minority Interest shows it stood at $363000.0 in 2020, then decreased by 23.14% to $279000.0 in 2021, then tumbled by 32.97% to $187000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Minority Interest are $187000.0 (Q4 2022), $279000.0 (Q4 2021), and $363000.0 (Q4 2020).